EFFECTS OF BACTERIAL LIPOPOLYSACCHARIDE AND SHIGA TOXIN ON INDUCED PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELLS

被引:1
|
作者
Martire-Greco, Daiana [1 ]
La Greca, Alejandro [2 ]
Castillo Montanez, Luis [1 ]
Biani, Celeste [2 ]
Lombardi, Antonella [2 ]
Birnberg-Weiss, Federico [1 ]
Norris, Alessandra [2 ]
Sacerdoti, Flavia [3 ]
Amaral, Maria Marta [3 ]
Rodrigues-Rodriguez, Nahuel [1 ]
Pittaluga, Jose Ramon [1 ]
Furmento, Veronica Alejandra [2 ]
Landoni, Veronica Ines [1 ]
Miriuka, Santiago Gabriel [2 ]
Luzzani, Carlos [2 ]
Fernandez, Gabriela Cristina [1 ]
机构
[1] Inst Med Expt IMEX CONICET, Acad Nacl Med, Lab Fisiol Proc Inflamatorios, Buenos Aires, DF, Argentina
[2] FLENI CONICET, Inst Neurociencias INEU, Lab Invest Aplicada Neurociencias LIAN, Buenos Aires, DF, Argentina
[3] Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Fac Med, Dept Fisiol, Lab Fisiopatogenia, Buenos Aires, DF, Argentina
来源
SHOCK | 2023年 / 59卷 / 06期
关键词
Mesenchymal stem cells; endothelial injury; bacterial toxins; tissue regeneration; hemolytic uremic syndrome; ESCHERICHIA-COLI; GENERATION; PACKAGE;
D O I
10.1097/SHK.0000000000002126
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Mesenchymal stem cells (MSCs) can be activated by different bacterial toxins. Lipopolysaccharides and Shiga Toxin (Stx) are the main toxins necessary for hemolytic uremic syndrome development. The main etiological event in this disease is endothelial damage that causes glomerular destruction. Considering the repairing properties of MSC, we aimed to study the response of MSC derived from induced pluripotent stem cells (iPSC-MSC) to LPS and/or Stx and its effect on the restoration of injured endothelial cells. Methods: iPSC-MSC were treated with LPS and or/Stx for 24 h and secretion of cytokines, adhesion, and migration were measured in response to these toxins. In addition, conditioned media from treated iPSC-MSC were collected and used for proteomics analysis and evaluation of endothelial cell healing and tubulogenesis using human microvascular endothelial cells 1 as a source of endothelial cells. Results: The results obtained showed that LPS induced a proinflammatory profile on iPSC-MSC, whereas Stx effects were less evident, even though cells expressed the Gb(3) receptor. Moreover, LPS induced on iPSC-MSC an increment in migration and adhesion to a gelatin substrate. Addition of conditioned media of iPSC-MSC treated with LPS + Stx, decreased the capacity of human microvascular endothelial cells 1 to close a wound, and did not favor tubulogenesis. Proteomic analysis of iPSC-MSC treated with LPS and/or Stx revealed specific protein secretion patterns that support the functional results described. Conclusions: iPSC-MSC activated by LPS acquired a proinflammatory profile that induces migration and adhesion to extracellular matrix proteins but the addition of Stx did not activate any repair program to ameliorate endothelial damage, indicating that the use of iPSC-MSC to regenerate endothelial injury caused by LPS and/or Stx in hemolytic uremic syndrome could not be the best option to consider to regenerate a tissue injury.
引用
收藏
页码:941 / 947
页数:7
相关论文
共 50 条
  • [1] Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
    Dupuis, Victoria
    Oltra, Elisa
    WORLD JOURNAL OF STEM CELLS, 2021, 13 (08): : 1094 - 1111
  • [2] Generation and Applications of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
    Zhao, Chengzhu
    Ikeya, Makoto
    STEM CELLS INTERNATIONAL, 2018, 2018
  • [3] The therapeutic effects of induced pluripotent stem cell-derived mesenchymal stem cells on Parkinson's disease
    Ren, Hao
    Wang, Yuwei
    Chen, Yingying
    Ma, Feilong
    Shi, Qing
    Wang, Zichen
    Gui, Yaoting
    Liu, Jianbo
    Tang, Huiru
    IUBMB LIFE, 2025, 77 (01)
  • [4] Immunomodulatory Properties of Induced Pluripotent Stem Cell-Derived Mesenchymal Cells
    Ng, Jia
    Hynes, Kim
    White, Gregory
    Sivanathan, Kisha Nandini
    Vandyke, Kate
    Bartold, Peter Mark
    Gronthos, Stan
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (12) : 2844 - 2853
  • [5] Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
    Galat, Vasiliy
    Galat, Yekaterina
    Perepitchka, Mariana
    Jennings, Lawrence J.
    Iannaccone, Philip M.
    Hendrix, Mary J. C.
    STEM CELLS AND DEVELOPMENT, 2016, 25 (14) : 1060 - 1072
  • [6] Comparative analysis of human induced pluripotent stem cell-derived mesenchymal stem cells and umbilical cord mesenchymal stem cells
    Rajasingh, Sheeja
    Sigamani, Vinoth
    Selvam, Vijay
    Gurusamy, Narasimman
    Kirankumar, Shivaani
    Vasanthan, Jayavardini
    Rajasingh, Johnson
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (18) : 8904 - 8919
  • [7] Effects of DLX3 on the osteogenic differentiation of induced pluripotent stem cell-derived mesenchymal stem cells
    Li, Junyuan
    Lin, Qiang
    Lin, Yixin
    Lai, Renfa
    Zhang, Wen
    MOLECULAR MEDICINE REPORTS, 2021, 23 (04)
  • [8] Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity
    Wruck, Wasco
    Graffmann, Nina
    Spitzhorn, Lucas-Sebastian
    Adjaye, James
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [9] Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells: Ushering of a New Era in Personalized Cell Therapies
    Pal, Rajarshi
    Mariappan, Indumathi
    Velayudhan, Shaji R.
    CURRENT STEM CELL RESEARCH & THERAPY, 2016, 11 (02) : 97 - 98
  • [10] Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells
    Chow, Lyndah
    Johnson, Valerie
    Regan, Dan
    Wheat, William
    Webb, Saiphone
    Koch, Peter
    Dow, Steven
    STEM CELL RESEARCH, 2017, 25 : 221 - 232